2015
DOI: 10.3109/15622975.2015.1066512
|View full text |Cite
|
Sign up to set email alerts
|

Cortical inhibition within motor and frontal regions in alcohol dependence post-detoxification: A pilot TMS-EEG study

Abstract: Our study provides first direct evidence of reduced cortical inhibition in the PFC of ALD patients post-detoxification. Altered cortical excitability in the MC may reflect hyper-excitability within the cortex associated with chronic alcohol consumption. These findings provide initial neurophysiological evidence of disrupted cortical excitability within the PFC of ALD patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
32
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 27 publications
(36 citation statements)
references
References 49 publications
0
32
0
Order By: Relevance
“…In healthy controls, acute ethanol exposure leads to an increase in the duration of the cortical silent period (Ziemann et al, 1995;Conte et al, 2008). Despite this acute change, CSP is not altered in individuals who have consumed alcohol chronically (Conte et al, 2008;Nardone et al, 2010b;Naim-Feil et al, 2016), even during withdrawal states (Nardone et al, 2010b). Similarly, inhibition can be enhanced and facilitation reduced by acute alcohol consumption in healthy controls (Ziemann et al, 1995), but no difference in magnitude could be found among detoxified individuals with a history of chronic alcohol use (Nardone et al, 2010a,b;Naim-Feil et al, 2016), despite facilitation being increased in withdrawal states (Nardone et al, 2010b).…”
Section: Using Transcranial Magnetic Stimulation Tomentioning
confidence: 99%
“…In healthy controls, acute ethanol exposure leads to an increase in the duration of the cortical silent period (Ziemann et al, 1995;Conte et al, 2008). Despite this acute change, CSP is not altered in individuals who have consumed alcohol chronically (Conte et al, 2008;Nardone et al, 2010b;Naim-Feil et al, 2016), even during withdrawal states (Nardone et al, 2010b). Similarly, inhibition can be enhanced and facilitation reduced by acute alcohol consumption in healthy controls (Ziemann et al, 1995), but no difference in magnitude could be found among detoxified individuals with a history of chronic alcohol use (Nardone et al, 2010a,b;Naim-Feil et al, 2016), despite facilitation being increased in withdrawal states (Nardone et al, 2010b).…”
Section: Using Transcranial Magnetic Stimulation Tomentioning
confidence: 99%
“…Naim‐Feil et al () also found disrupted cortical excitability and reduced cortical inhibition in their prefrontal cortex stimulation TMS–EEG study. Our results are in line with these findings, although the aforementioned measurements were conducted on adults with an over 10‐year history of alcohol dependence during the post‐detoxification and a different study paradigm was used.…”
Section: Discussionmentioning
confidence: 91%
“…So far, however, only one TMS–EEG study has examined the effects of long‐term alcohol use. Reduced cortical inhibition after prefrontal cortex stimulation in the post‐detoxification of alcohol‐dependent patients was reported, suggesting that cortical hyper‐excitability is associated with chronic alcohol use (Naim‐Feil et al ).…”
Section: Introductionmentioning
confidence: 99%
“…It should be noted that although the scope of this review was focused on TMS‐EEG biomarkers for MDD, BPD, and SCZ, there are a number of promising studies that have brought insights into the clinical neurophysiology of other psychiatric disorders, including attention‐deficit hyperactive disorder and autism . Very recently, TMS‐EEG has also been used to investigate the neural and network changes underlying substance‐use disorders . Future work in this field should focus on replicating these findings across different patient groups and different stages of the disorders, to help establish the reliability of these TMS‐EEG biomarkers and utilize concurrent pharmacological methodology to gain further insight into the neurobiological targets of these TMS indexes.…”
Section: Resultsmentioning
confidence: 99%
“…72,73 Very recently, TMS-EEG has also been used to investigate the neural and network changes underlying substance-use disorders. 74 Future work in this field should focus on replicating these findings across different patient groups and different stages of the disorders, to help establish the reliability of these TMS-EEG biomarkers and utilize concurrent pharmacological methodology to gain further insight into the neurobiological targets of these TMS indexes.…”
Section: Resultsmentioning
confidence: 99%